Incyte (INCY) Shares Outstanding (2010 - 2026)

Incyte (INCY) posted Shares Outstanding (Entity) of $199.9 million for Q1 2026, up 0.75% on a QoQ basis from $198.5 million in Q4 2025, and up 3.18% year-over-year from $193.8 million in Q1 2025.

Incyte (INCY) Shares Outstanding (2010 - 2026) Analysis & Trends

Incyte's Shares Outstanding (Entity) history runs 17 years deep, the most recent figure standing at $199.9 million for Q1 2026.

  • Quarterly Shares Outstanding (Entity) rose 3.18% year-over-year to $199.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $199.9 million (up 3.18% YoY) and the FY2025 annual result came in at $198.5 million, up 2.6% from the prior year.
  • Shares Outstanding (Entity) was $199.9 million for Q1 2026 at Incyte, up from $198.5 million in the prior quarter.
  • Across five years, Shares Outstanding (Entity) topped out at $224.5 million in Q1 2024 and bottomed at $191.6 million in Q2 2024.
  • A 5-year average of $209.9 million and a median of $221.4 million in 2022 frame the typical range for Shares Outstanding (Entity).
  • Annual changes were most pronounced in 2024 — Shares Outstanding (Entity) declined 14.22% — and 2026, when it climbed 3.18%.
  • Incyte's Shares Outstanding (Entity) stood at $222.7 million in 2022, then advanced by 0.69% to $224.3 million in 2023, then slipped by 13.76% to $193.4 million in 2024, then gained by 2.6% to $198.5 million in 2025, then gained by 0.75% to $199.9 million in 2026.
  • Business Quant data shows INCY's Shares Outstanding (Entity) at $199.9 million in Q1 2026, $198.5 million in Q4 2025, and $196.1 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares Outstanding (Qtr)
1 Oculis Holding AG 67,072.09 Bn 67,072.09 Bn - 6,012.74 Bn
2 Nanobiotix 1,894.61 Bn 1,894.55 Bn - 47.82 Bn
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - 118.76 Bn
4 BeOne Medicines 471.64 Bn 466.85 Bn 1.35 Bn 1.44 Bn
5 Vertex Pharmaceuticals 121.72 Bn 114.47 Bn 2.59 Bn 254.10 Mn
6 Regeneron Pharmaceuticals 68.28 Bn 59.52 Bn 3.31 Bn 104.00 Mn
7 Belite Bio 61.40 Bn 61.40 Bn - 400.00 Mn
8 Argenx Se 56.94 Bn 56.94 Bn 1.18 Bn 62.06 Mn
9 Revolution Medicines 37.37 Bn 37.37 Bn - 198.10 Mn
10 Incyte 23.47 Bn 19.46 Bn 1.17 Bn 199.34 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 199.34 Mn
Dec 31, 2025 195.20 Mn
Sep 30, 2025 195.67 Mn
Jun 30, 2025 194.00 Mn
Mar 31, 2025 193.71 Mn
Dec 31, 2024 207.11 Mn
Sep 30, 2024 192.63 Mn
Jun 30, 2024 218.18 Mn
Mar 31, 2024 224.48 Mn
Dec 31, 2023 223.63 Mn
Sep 30, 2023 224.08 Mn
Jun 30, 2023 223.25 Mn
Mar 31, 2023 222.96 Mn
Dec 31, 2022 222.00 Mn
Sep 30, 2022 222.42 Mn
Jun 30, 2022 221.66 Mn
Mar 31, 2022 221.33 Mn
Dec 31, 2021 220.43 Mn
Sep 30, 2021 220.85 Mn
Jun 30, 2021 220.08 Mn